mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.078 |
0.2 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.072 |
0.2 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.073 |
0.2 |